Last updated on: 1/22/2010 | Author:

Donald S. Nelinson, PhD Biography

President of InterQuest Medical & Scientific Communications
Pro to the question "Is Obesity a Disease?"

“Obesity meets all accepted criteria of a medical disease, including a known etiology, recognized signs and symptoms, and a range of structural and functional changes that culminate in pathologic consequences. Excess adipose tissue acts as an endocrine organ to produce excess free fatty acids, as well as tumor necrosis factor-รก, interleukin-6, leptin, and plasminogen activator inhibitor-1. These bioactive molecules are associated with hyperinsulinemia, hyperglycemia, insulin resistance, development of diabetes, endothelial damage, and the onset and progression of atherosclerotic lesions.”

“Obesity as a Disease State: A New Paradigm for Diagnosis and Treatment,” Clinical Cornerstone, 2009

Involvement and Affiliations:
  • President, InterQuest Medical & Scientific Communications
  • Managing Director, Convergence 360
  • Founder and Director, Diabetes Consortium, Inc.
  • Executive Vice President and Scientific Director, Torre Lazur McCann
  • Advisor, Aton Pharma
  • Consultant, Lions Eye Institute for Transplant and Research
  • Senior Vice President and Scientific Director, Nelson Communications, Oct. 2002-Sep. 2004
  • Vice President for Education, Physicians World, 1999-2001
  • Vice President of Medical Education, Impact Communications, 1996-2000
  • Fellow, National Institute of Mental Health (NIMH), 1982-1984
  • PhD, University of Maryland at Baltimore, 1991
  • Attended Loyola College in Maryland, 1976-1981
  • Attended University of Vermont, 1972-1976
  • None found